SCHEMBL19903684

SCHEMBL19903684

N#Cc1c(-n2c3ccccc3c3ccc4c5ccccc5n(-c5ccccc5)c4c32)cc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1-n1c2ccccc2c2ccc3c4ccccc4n(-c4ccccc4)c3c21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KIF11 P52732 1/20 0.36
CTSK P43235 2/20 0.34
KDR P35968 2/20 0.34
ALDH1A1 P00352 3/20 0.34
LMNA P02545 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
MAT2A P31153 1/20 0.33
RXRA P19793 1/20 0.33
RXRG P48443 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
HPGD P15428 1/20 0.33
PPARG P37231 1/20 0.32
PPARA Q07869 1/20 0.32
MAPT P10636 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
ICMT O60725 1/20 0.31
TACR1 P25103 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20617079 0.95 RXRA (0.40) KDM4EATML3MBTL1KIF11CTSK
SCHEMBL19912398 0.93 KDM4E (0.37) KDM4EATML3MBTL1KIF11CTSK
SCHEMBL19903463 0.89 KDM4E (0.41) KDM4EATML3MBTL1KIF11CTSK
SCHEMBL19903495 0.88 KIF11 (0.39) KDM4EATML3MBTL1KIF11ALDH1A1
SCHEMBL19903596 0.88 KDM4E (0.40) KDM4EATML3MBTL1KIF11CTSK
SCHEMBL20617097 0.87 RXRA (0.38) KDM4EATML3MBTL1KIF11CTSK
SCHEMBL19917970 0.86 KIF11 (0.37) KDM4EATML3MBTL1KIF11KDR
SCHEMBL19903640 0.86 KIF11 (0.37) KDM4EATML3MBTL1KIF11KDR
SCHEMBL26496658 0.85 KDM4E (0.40) KDM4EATML3MBTL1KIF11CTSK
SCHEMBL19903679 0.85 KDM4E (0.30) KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10439151-B2 Organic molecules, especially for use in organic optoelectronic devices CYNORA GMBH (DE) 2019-10-08 US disclosed
EP-3287450-B1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-03-20 EP disclosed
US-20180062086-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
EP-3287450-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10439151-B2 Organic molecules, especially for use in organic optoelectronic devices OR10J3, ORC3, AOC3 KDM4E 3469/4885ATM 3091/4885L3MBTL1 4117/4885
US-20180062086-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, ORC3, AOC3 KDM4E 3559/4885ATM 3056/4885L3MBTL1 4013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.